Overview

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial on the assumption that abraxane and cisplatin combination therapy is efficacy in metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel